GlassScriptPhysician profile
Robert Wozniak
NPI 1942282470
$14,571.82
in general payments reported to CMS, 2019-2025
65 companies · $1,627 in 2025
The $1,627 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,095 · 2020: $1,894 · 2021: $2,098 · 2022: $2,218 · 2023: $2,927 · 2024: $1,714 · 2025: $1,627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,267.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,772.57 | 2019-2025 | Mounjaro, Humulin, Trulicity |
| Sanofi-Aventis U.S. LLC | $1,281.48 | 2019-2025 | |
| Abbott Laboratories | $1,168.67 | 2019-2025 | Freestyle Libre 3, Eterna |
| Mannkind Corporation | $866.06 | 2019-2025 | Afrezza |
| Novo Nordisk INC | $738.84 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Corcept Therapeutics | $719.84 | 2019-2025 | Korlym |
| Astrazeneca Pharmaceuticals LP | $657.42 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $566.95 | 2019-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $506.36 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $452.62 | 2019-2024 | Unithroid |
| Merck Sharp & Dohme LLC | $377.34 | 2019-2022 | |
| Dexcom, INC. | $374.68 | 2019-2025 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $347.39 | 2019-2022 | |
| Amgen INC. | $332.33 | 2019-2025 | Tepezza, Repatha, Prolia |
| Ibsa Pharma INC. | $329.69 | 2019-2025 | Tirosint, Licart, Flector |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $299.17 | 2020-2022 | |
| Echosens North America, INC. | $293.12 | 2025 | Fibroscan |
| Insulet Corporation | $256.80 | 2019-2025 | Omnipod |
| Cequr Corporation | $227.45 | 2022-2025 | Cequr Simplicity |
| Amryt Pharma Holdings LTD | $215.43 | 2021-2023 | Mycapssa |
| Beta Bionics, INC. | $204.80 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Abbvie INC. | $187.97 | 2020-2024 | Synthroid |
| Medtronic, INC. | $186.55 | 2021-2025 | Minimed 780g, Abre |
| Xeris Pharmaceuticals, INC. | $175.06 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Inspire Medical Systems, INC. | $138.63 | 2023 | Inspire |
| Ascendis Pharma Endocrinology INC | $115.28 | 2023-2025 | Yorvipath |
| Recordati_rare_diseases_inc. | $113.81 | 2021-2024 | Signifor Lar, Isturisa |
| Pfizer INC. | $99.88 | 2020-2024 | |
| Tandem Diabetes Care, INC. | $95.92 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ipsen Biopharmaceuticals, INC | $80.83 | 2020-2021 | |
| Medtronic Minimed, INC. | $70.92 | 2019-2020 | |
| Vistapharm, INC. | $69.52 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.10 | 2020-2021 | |
| Ultragenyx Pharmaceutical INC. | $68.50 | 2019-2023 | |
| Becton, Dickinson and Company | $65.03 | 2021 | |
| Ascensia Diabetes Care US INC. | $60.71 | 2023-2024 | |
| Lifescan, INC. | $60.41 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $58.26 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $57.12 | 2024-2025 | |
| Renalytix Ai, INC. | $54.36 | 2022-2023 | Kidneyintelx Blood Collection Convenience Kit |
| Chiesi USA, INC. | $52.33 | 2024-2025 | Mycapssa, Myalept |
| Nevro Corp. | $51.56 | 2024 | Senza |
| Tolmar, INC. | $45.83 | 2023-2025 | Jatenzo |
| Esperion Therapeutics, INC. | $45.66 | 2021 | |
| Companion Medical, INC. | $41.81 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $40.85 | 2019-2020 | |
| Almatica Pharma LLC | $38.50 | 2025 | Teriparatide |
| Antares Pharma, INC. | $38.10 | 2019-2021 | |
| Clarus Therapeutics INC. | $37.41 | 2021 | |
| Aytu Biopharma, INC. | $36.63 | 2019-2020 | |
| Embecta Corp. | $36.03 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Amphastar Pharmaceuticals, INC. | $34.42 | 2025 | |
| Acerus Pharmaceuticals Corporation | $33.91 | 2021-2023 | Natesto |
| Novartis Pharmaceuticals Corporation | $23.90 | 2022 | |
| Globus Medical, INC. | $23.59 | 2025 | Omnia |
| Rhythm Pharmaceuticals, INC. | $21.50 | 2025 | Imcivree |
| Shire North American Group INC | $20.55 | 2019 | |
| Senseonics, Incorporated | $20.00 | 2019 | |
| Madrigal Pharmaceuticals | $17.71 | 2025 | Rezdiffra |
| Vifor Pharma, INC. | $17.11 | 2019 | |
| Valeritas, INC. | $17.02 | 2019 | |
| Grt US Holding, INC. | $16.74 | 2021 | |
| Zealand Pharma US, INC. | $15.67 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.56 | 2019 | |
| Acella Pharmaceuticals, LLC | $12.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wozniak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.